234 related articles for article (PubMed ID: 33127247)
1. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
[TBL] [Abstract][Full Text] [Related]
2. Endovascular treatment of type 3 and 4 thoracic central vein obstruction in hemodialysis patients.
Uceda PV; Feldtman RW; Peralta J; Ahn SS
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):643-651.e3. PubMed ID: 33096274
[TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Abre Self-Expanding Venous Stent for Treatment of Superior Vena Cava Syndrome.
An TJ; McNamara SL; Ardestani A; Zurkiya O; Cahalane A; Stecker MS; Epelboym Y; Burch E; Desai K; Kalva SP
Vasc Endovascular Surg; 2024 Aug; 58(6):617-622. PubMed ID: 38670555
[TBL] [Abstract][Full Text] [Related]
4. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis.
Deshwal H; Ghosh S; Magruder K; Bartholomew JR; Montgomery J; Mehta AC
Vasc Med; 2020 Apr; 25(2):174-183. PubMed ID: 31804157
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction.
Han TM; Bondarev S; Keller EJ; Vogelzang RL; Resnick SA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):939-944. PubMed ID: 32414673
[TBL] [Abstract][Full Text] [Related]
6. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
7. Endovascular management of central thoracic veno-occlusive diseases in hemodialysis patients: a single institutional experience in 69 consecutive patients.
Nael K; Kee ST; Solomon H; Katz SG
J Vasc Interv Radiol; 2009 Jan; 20(1):46-51. PubMed ID: 19019699
[TBL] [Abstract][Full Text] [Related]
8. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic superior vena cava syndrome in hemodialysis patients: mid-term results of primary stenting.
Massara M; De Caridi G; Alberti A; Volpe P; Spinelli F
Semin Vasc Surg; 2016 Dec; 29(4):186-191. PubMed ID: 28779785
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
[TBL] [Abstract][Full Text] [Related]
11. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
[TBL] [Abstract][Full Text] [Related]
12. Pericardial tamponade after superior vena cava stent: are nitinol stents safe?
Khalid I; Omari M; Khalid TJ; Castillo E; Khandelwal A; Kattoo R
Asian Cardiovasc Thorac Ann; 2010 Jun; 18(3):294-6. PubMed ID: 20519302
[TBL] [Abstract][Full Text] [Related]
13. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
14. Endovascular Treatment of Superior Vena Cava Syndrome via Balloon-in-Balloon Catheter Technique with a Palmaz Stent.
Shatila W; Almanfi A; Massumi M; Dougherty KG; Parekh DR; Strickman NE
Tex Heart Inst J; 2016 Dec; 43(6):520-523. PubMed ID: 28100973
[TBL] [Abstract][Full Text] [Related]
15. Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis-A Feasibility and Safety Analysis.
Majumdar S; Shoela R; Kim DJ; Ramaswamy R; Mani N; Salter A; Akinwande O
Vasc Endovascular Surg; 2018 Apr; 52(3):202-206. PubMed ID: 29433409
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Covered Versus Uncovered Stents for Benign Superior Vena Cava (SVC) Obstruction.
Haddad MM; Simmons B; McPhail IR; Kalra M; Neisen MJ; Johnson MP; Stockland AH; Andrews JC; Misra S; Bjarnason H
Cardiovasc Intervent Radiol; 2018 May; 41(5):712-717. PubMed ID: 29492630
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous treatment of superior vena cava syndrome using metallic stents.
de Gregorio Ariza MA; Gamboa P; Gimeno MJ; Alfonso E; Mainar A; Medrano J; López-Marin P; Tobio R; Herrera M
Eur Radiol; 2003 Apr; 13(4):853-62. PubMed ID: 12664126
[TBL] [Abstract][Full Text] [Related]
18. Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome.
Maleux G; Gillardin P; Fieuws S; Heye S; Vaninbroukx J; Nackaerts K
AJR Am J Roentgenol; 2013 Sep; 201(3):667-74. PubMed ID: 23971462
[TBL] [Abstract][Full Text] [Related]
19. Endovascular recanalization for nonmalignant obstruction of the inferior vena cava.
Erben Y; Bjarnason H; Oladottir GL; McBane RD; Gloviczki P
J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):173-182. PubMed ID: 29337042
[TBL] [Abstract][Full Text] [Related]
20. Braided or laser-cut self-expanding nitinol stents for the common femoral vein in patients with post-thrombotic syndrome.
Moeri L; Lichtenberg M; Gnanapiragasam S; Barco S; Sebastian T
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):760-769. PubMed ID: 32890743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
